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Abstract
Background: Streptococcus mutans is a major pathogen in human dental caries. One of its important virulence
properties is the ability to form biofilms (dental plaque) on tooth surfaces. Eradication of such biofilms is extremely
difficult. We therefore screened a library of secondary metabolites from myxobacteria for their ability to damage
biofilms of S. mutans.
Results: Here we show that carolacton, a secondary metabolite isolated from Sorangium cellulosum, has high
antibacterial activity against biofilms of S. mutans. Planktonic growth of bacteria was only slightly impaired and no
acute cytotoxicity against mouse fibroblasts could be observed. Carolacton caused death of S. mutans biofilm cells,
elongation of cell chains, and changes in cell morphology. At a concentration of 10 nM carolacton, biofilm
damage was already at 35% under anaerobic conditions. A knock-out mutant for comD, encoding a histidine
kinase specific for the competence stimulating peptide (CSP), was slightly less sensitive to carolacton than the
wildtype. Expression of the competence related alternate sigma factor ComX was strongly reduced by carolacton,
as determined by a pcomX luciferase reporter strain.
Conclusions: Carolacton possibly interferes with the density dependent signalling systems in S. mutans and may
represent a novel approach for the prevention of dental caries.
Background
Biofilms that harbour pathogenic bacteria are a serious
health problem of increasing importance. They have
been implicated in many persistent and chronic diseases
such as cystic fibrosis, endocarditis, and infections
caused by biofilms growing on incorporated foreign
materials, e.g. stents, indwelling catheters, bone
implants, and artificial valves [1-5]. Dental caries and
periodontal diseases, which are among the most
common bacterial infections in humans, are caused by
biofilms known as dental plaque that result from micro-
bial colonization of the tooth surface or the subgingival
margin [6,7].
Eradication of biofilm bacteria by conventional antibio-
tic therapy is notoriously difficult or almost impossible
due the much higher resistance level of the cells that is
partially caused by the barrier effect of the exopolysac-
charide matrix, and more importantly by profound
genetic and metabolic adaptations of the cells to a sessile
mode of growth [4,8,9]. It has been estimated that
bacteria embedded in biofilms are more than 1000-fold
less susceptible to the effects of commonly used antimi-
crobial compounds than are their planktonic counter-
parts [8,10,11]. Thus novel strategies for battling
clinically relevant biofilms are urgently needed, particu-
larly if one takes into consideration that biofilm-forming
bacteria account for about two-thirds of human bacterial
infections [10]. Quorum sensing systems might be pro-
mising targets in treating biofilm-induced infections.
These intercellular communication mechanisms are
mediated by extracellular small signalling molecules
(autoinducers) and coordinate population wide gene
expression of e.g. virulence factors such as biofilm
formation in a cell-density-dependent manner [2,12].
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specifically attenuate virulence might represent an attrac-
tive alternative to conventional antibiotic therapy, parti-
cularly considering the fact that these antibacterial
compounds are less likely to induce the development of
resistant bacteria.
Such a “p r o o fo fc o n c e p t ” has already been provided
by mimics of the acylated homoserine lactone signalling
molecules, such as synthetic derivatives of natural fura-
nones, which are able to inhibit in vivo biofilm develop-
ment of Pseudomonas aeruginosa [13], and when
covalently bound to surfaces also those of Staphylococ-
cus epidermidis [14]. Moreover the quorum-sensing
RNA III inhibiting peptide was shown to inhibit in vivo
biofilm formation of Staphylococcus aureus [15]. How-
ever none of the quorum sensing blockers tested in ani-
mal models so far was suitable for human use.
Our project is aimed at finding new inhibitors of bio-
film formation of the Gram-positive facultative anaero-
bic bacterium S. mutans. Among more than 500
bacterial species found in dental plaque [16-18]
S. mutans is considered to be the principal pathogen
causing human dental caries [19]. While metabolising
dietary carbohydrates, S. mutans rapidly produces acid
endproducts lowering the pH to approximately pH 3.5
resulting in demineralisation of the dental enamel and
caries formation [20-22]. Moreover S. mutans can be a
cause of subacute infective endocarditis [19,23].
We focused in our search for biofilm inhibitors on our
collection of secondary metabolites from myxobacteria.
They are ubiquitous Gram-negative soil bacteria charac-
terized by their ability to glide in swarms, as well as by
their complex life cycle that upon starvation culminates
in the formation of multicellular fruiting bodies, con-
taining dormant myxospores [24]. The complexity of
their social behaviour and morphogenetic potential is
reflected in their large genomes (9-13 Mbp), some of
which, e.g. Sorangium cellulosum So ce56 [25] have
been sequenced. The overrepresentation of genes
involved in secondary metabolism also explains the cap-
ability of myxobacteria to produce such a high number
of potentially useful low molecular weight compounds.
Over the past 25 years, more than 100 secondary meta-
bolites with more than 450 structural variants have been
isolated from myxobacteria at the HZI. Most of these
compounds turned out to be new and show novel unre-
lated structures as well as different biological activities
with interesting mechanisms of action [24,26,27]. About
a third of these myxobacterial compounds however did
not show any biological or biochemical effect in our test
battery, which until now predominantly focused at kill-
ing or inhibiting microbial growth. It should be pointed
out that especially these compounds are of interest in
exploring new targets.
Here we report on the efficacy of the secondary meta-
bolite carolacton produced by S. cellulosum to biofilms
of the cariogenic bacterium S. mutans.F i g u r e1s h o w s
the structure of carolacton [28,29], the elucidation of
which as well as its production and isolation have been
reported elsewhere [30]. Carolacton induced damage of
S. mutans biofilms at nanomolar concentrations, while
planktonic growth was only weakly affected.
Results
Effect of carolacton on planktonic growth of bacteria and
on eukaryotic cells
Carolacton has been reported to be inactive in standard
bacterial growth inhibition tests using suspended (plank-
tonic) cultures of Gram positive and Gram negative test
strains [31] at least up to the highest tested concentra-
tion of 40 μg/mL (85 μM) [28]. The only sensitive strain
was E. coli strain tolC (MIC 0.006 μg/ml) which is char-
acterized by a defect in the TolC protein, a component
of a multidrug efflux pump located in the outer
membrane [32], making it hypersensitive to antibiotics. A
minor antifungal activity (at 16 - 20 μg/mL) has been
described against various filamentous fungi, e.g. Aspergil-
lus niger, Phytium debaryanum,a n dSclertina sclerotiorum
[30]. Because of our biofilm screening results (see below)
we determined the antibiotic activity of carolacton against
S. mutans UA159 grown in planktonic culture. Carolacton
only weakly inhibited growth under both aerobic and
anaerobic conditions (MIC >106 μM) as determined in a
conventional serial dilution assay. The turbidity of cultures
(OD620) after 18-24 hours of incubation was reduced by
10-25% at concentrations of carolacton between 26.6 and
106 μM, respectively. Microscopical analysis showed that
carolacton induced longer cell chains (see below), which
might have contributed to the reduction in OD620.
Carolacton showed no acute toxicity in cell culture
assays with L929 mouse fibroblasts. After 18 hours of
incubation no inhibition of the metabolic activity of the
cells was indicated by an MTT assay up to the highest
tested concentration (79 μM). In all experiments the
level of cytoplasmic histone-associated DNA fragments
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Figure 1 Chemical structure of carolacton (from Ref. [30],w i t h
permission).
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Page 2 of 13was below 1% of the positive control, thus no sign of
apoptosis could be observed (again up to the highest
tested concentration of 79 μM).
Effect of carolacton on cell morphology and viability of
S. mutans
Phase contrast/fluorescence microscopy in combination
with LIVE/DEAD BacLight bacterial viability staining
(details see below) revealed that the majority of the
biofilm cells of S. mutans g r o w na n a e r o b i c a l l yi nt h e
presence of carolacton (5.3 μM) showed red fluores-
cence, indicating damaged membranes and possibly
death of the cells (Figure 2D), while planktonic cells were
fluorescing green like untreated controls (Figure 2B). In
addition, changes in cell morphology were observed, both
in planktonic culture and in biofilms. In carolacton trea-
ted planktonic cultures cells appeared elongated, tended
to form longer chains and some cells formed bulges, both
as individuals and when growing in chains (Figure 2B),
suggesting that cell division or acid tolerance could be
influenced by carolacton. Nearly all of the planktonic
cells were stained green, including also the balloon-like
ones, which indicated that these cells too, were viable.
Carolacton treated biofilm cells (Figure 2D) showed
similar morphological modifications, yet many of the
cells, including also most of the balloon-like ones, were
stained red. Thus, the membrane damage resulting from
carolacton treatment appears to be specific for biofilm
cells. Although the microscopical observations in Figure
2 are not quantitative, they confirm that carolacton trea-
ted planktonic cultures had a slightly reduced density
compared to untreated controls.
Quantification of S. mutans biofilm damage by carolacton
We attempted to quantify the extent of biofilm damage
caused by carolacton by determining colony forming
units (CFU). Figure 3 shows that the number of CFU in
carolacton treated biofilms was only 5 - 15% compared
to untreated controls, thus confirming that carolacton
induced cell death. Due to the microscopic observations
described above, these results have to be interpreted
cautiously, because not only the high percentage of red
stained biofilm cells, but also the elongated cell chains
reduced the viable cell count. Disaggregation of these
chains by sonification failed to yield individual cells or
short chains comparable to untreated cultures and led
to more or less complete cell death.
Therefore, we used the LIVE/DEAD BacLight bacterial
viability staining as a sensitive and fast method for
quantifying the effect of carolacton on biofilm viability
of S. mutans. Biofilm damage was calculated as the ratio
of green versus red fluorescence of the biofilm cells nor-
malized against the untreated control. This parameter is
indicative of the membrane integrity of the cells, since
Figure 2 Effect of carolacton on cell morphology and viability.
Fluorescent phase-contrast images of planktonically grown cultures
(A, B) and biofilm cells of S. mutans (C, D) after LIVE/DEAD staining
without (A, C) and in the presence of 5.3 μM carolacton (B, D).
Planktonic cultures were grown in THB. Biofilms were grown in THB
supplemented with 0.5% sucrose on microtitre plates for 24 h
hours. Cultivation was at 37°C under anaerobic conditions (80% N2,
10% H2, 10% CO2). For microscopy, biofilm cells were scraped off
from the bottom of the wells using pipette tips. Samples (100 μl)
were stained with LIVE/DEAD BacLight bacterial viability staining kit
L13152 (Molecular Probes; Eugene, OR, US) as recommended by the
manufacturer and analysed using an Olympus BX60 microscope
equipped with fluorescence filters U-MWB and U-MNUA2 and the
Olympus digital camera Color View II (Olympus Optical Co., Ltd.
Germany). Arrows (B, D) indicate bulging cells.
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damaged membranes. For S. mutans,ac a l i b r a t i o nc u r v e
using isopropyl alcohol-killed and live cells in varying
proportions resulted in a linear correlation between the
ratio of green to red fluorescence and the amount of
live cells (data not shown). For carolacton treated cells,
Figure 3 shows that the extent of biofilm damage calcu-
lated from fluorescence staining was much smaller than
that obtained by CFU counting. Thus, the green/red
ratio of fluorescence is a conservative estimate of biofilm
damage in S. mutans.
Dose-dependent damage of biofilms of S. mutans by
carolacton
Biofilm damage was determined for 24 h old biofilms of
S. mutans grown under anaerobic conditions, which
predominate in dental plaque, using concentrations of
carolacton between 0.0053 μM and 106.5 μM. As shown
in Figure 4, carolacton decreased biofilm viability over a
concentration range of three orders of magnitude (from
0.053 μMt o5 3μM) to approximately the same degree
(55 - 65%). At a concentration of 0.01 μM( 5n g / m l )
carolacton, biofilm damage was already 35%. This type
of dose-response relationship is typical for quorum
sensing controlled processes. A very low inducing
threshold concentration is followed by a broad satura-
tion range, resulting in the lack of a linear relationship
between signal concentration and response [33].
Time course of biofilm damage by carolacton
We next investigated the dynamics of biofilm growth
and its disturbance by carolacton during the first 24 h
under anaerobic conditions. Green fluorescence of
biofilms stained with SYTO9 alone is a measure of the
total amount of biofilm cells, both alive and membrane
damaged, and was applied here to study the growth of
S. mutans biofilms with and without carolacton. Figure
5A shows two typical time courses for biofilm growth.
In the untreated control, the amount of biofilm cells
reached its maximum after 8 - 12 h, followed by
a plateau and sometimes by a slow decrease, presumably
due to detachment of biofilm fragments in the mature
biofilm. During these first 12 h of biofilm growth, caro-
lacton (5.3 μM) reduced the total amount of biofilm cells,
as determined by total green fluorescence, up to 54%, but
this effect was not observed any more after 24 h.
Membrane damage of the biofilm cells, determined by
the LIVE/DEAD BacLight fluorescence staining method
by staining with both SYTO9 (green) and propidium
iodide (red), was calculated as the reduction of the green/
red fluorescence ratio in biofilms grown with carolacton
relative to untreated controls and is shown in Figure 5B
for three independent experiments. It shows a similar
pattern. Biofilm damage was small during the first 6 h,
increased rapidly until about 8.5 or 12.25 h, respectively
and then remained stable or increased more slowly till
the end of the experiment after 24 hours. The curves for
the two concentrations of carolacton tested were very
similar, as expected from the concentration range
of carolacton activity determined previously (Figure 4).
The maximum reduction of the relative green/red fluor-
escence ratio was between 47% and 69% reflecting the
Figure 3 Quantification of the viability of carolacton treated S.
mutans biofilms determined by counting colony forming units
(CFU) and by measuring membrane damage, calculated as the
green/red ratio after LIVE/DEAD BacLight Bacterial Viability
staining in percent of untreated controls. Biofilms were grown
for 24 h under anerobic conditions. Each data point is the average
+/- standard deviation of triplicate to fourfold determinations. The
CFU in the control without carolacton was 2.1 × 10
7ml
-1.
Figure 4 Effect of carolacton concentration on the membrane
damage of S. mutans biofilms. Biofilms were grown for 24 h
under anaerobic conditions and stained using the LIVE/DEAD
BacLight Bacterial Viability kit. Green and red fluorescence was
determined, and biofilm damage was calculated as reduction of the
fluorescence ratio green/red compared to untreated controls. Each
data point is the average of triplicate samples. Standard deviations
are given for data points determined in at least three independent
experiments.
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from pH 7.8 to pH 4.3 (24 h of growth), but there was no
difference in controls and carolacton treated cultures. To
summarize, the data show that carolacton temporarily
reduced the total amount of biofilm cells, indicated by
staining with the green fluorescent dye alone, during the
period of maximum biofilm growth (Figure 5A). Most
importantly, carolacton strongly reduced the viability of
cells within the biofilm, determined by the reduction of
the relative proportion of green to red fluorescence,
throughout 24 h of biofilm development but mainly dur-
ing the period of maximum biofilm growth and there-
after, while little reduction of viability was observed
during the initial hours of biofilm growth (Figure 5B).
Investigation of the effect of carolacton on S. mutans
biofilms by confocal laser scanning microscopy
The effect of carolacton on the spatial distribution,
architecture and viability of biofilms of wild-type S.
mutans UA159 was investigated by confocal laser
Figure 5 Time course of biofilm growth of S. mutans in the presence and absence of carolacton. A Biofilm volume, determined by using
only the SYTO9 (green) component of the LIVE/DEAD BacLight Bacterial Viability stain. Two representative experiments are shown. Green
fluorescence, which is a measure of total biomass, is shown in absolute units. B Biofilm membrane damage, determined using the LIVE/DEAD
BacLight Bacterial Viability stain. Green and red fluorescence was measured, and biofilm damage was calculated as reduction of the ratio of
green/red fluorescence compared to controls without carolacton. Error values were calculated from the standard deviations of the green/red
ratios of control and carolacton treated samples according to the error propagation formula of Gauss. Three representative experiments are
shown. Biofilms were grown anaerobically. Mean and standard deviation are given for triplicate samples.
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flanked by pictures of vertical optical sections after 12
hours of cultivation and Figure 6B represents horizontal
sections at a higher magnification. Control biofilms
showed a characteristic architecture with pancake like
cell clusters distributed randomly over the substratum,
occasionally growing together but leaving biofilm free
spaces in between them. Control biofilms also showed
rare signs of membrane damage which initiated at the
substratum-oriented side of the biofilm. In biofilms
grown in the presence of carolacton, a significant part
of the cells was stained red, indicating that cell mem-
brane integrity was severely damaged. Vertical optical
sections show that membrane damage occurred
Figure 6 Confocal laser scanning microscope images of S. mutans biofilms in the absence (A) or presence (B) of 0.5 μM carolacton
after 12 h of anaerobic cultivation. Staining using the LIVE/DEAD BacLight Bacterial Viability Kit assessed bacterial viability: green areas
indicate live cells; red areas indicate dead or damaged cells. The top panel shows a bird’s eye view on the biofilm with lines indicating the
position of the vertical sections shown at the lower and right margins of both images. Acquired using an UPLSAPO 20× objective lens, size of
scale bar 50 μm. The bottom panel shows enlarged horizontal sections of S. mutans biofilms in the absence (A) or presence (B) of 0.5 μM
carolacton, aacquired using an UPLSAPO 40× objective lens with 7× digital magnification, size of scale bar 5 μm.
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as well as towards the biofilm surface. Biofilm architec-
ture appeared less dense than in the controls, and small
cell clusters were scattered across the substratum with
little empty space in between them. The magnification
of the biofilms (Figure 6B) shows that the central
regions of cell clusters were affected most by carolacton.
Effect of carolacton on biofilms of quorum sensing
negative mutants
S. mutans utilizes a density-dependent quorum sensing
signalling system to regulate the expression of virulence
factors, including biofilm formation. It involves an
excreted autoinducer, the competence stimulating pep-
tide (CSP) encoded by comC, which is detected by a
two-component signal transduction system comprising
the histidine kinase ComD and the response regulator
ComE [34-38].
To find out if carolacton interferes with this system, we
tested its effect on biofilm formation of knockout
mutants for comC, comD and comE. Biofilms were grown
under anaerobic conditions in the presence of 0.53 μM
or 5.3 μM carolacton, respectively, and stained and ana-
lysed as described after 24 h of biofilm growth. For each
strain and carolacton concentration, between 3 and 5
experiments were carried out. The green/red fluores-
cence ratio for untreated controls was the same for the
wildtype and the three mutants. Figure 7 shows that bio-
films of the wild-type strain S. mutans were damaged by
carolacton with an average level of 61% (5.3 μM carolac-
ton) or 63% (0.0.53 μM carolacton). comC and comE
mutants showed slightly lower mean inhibition values,
but this difference was not statistically significant. Bio-
films of the comD mutant were only damaged by 40%
(5.3 μM carolacton) or 42% (0.53 μM carolacton) and the
difference to the wildtype was statistically significant for
both tested concentrations (one sided Student’st - t e s t ,
p = 0.019 and p = 0.032, respectively).
Thus, the comD knockout mutant was slightly less
sensitive to carolacton than the wildtype. This could
indicate that carolacton interferes with the membrane
bound histidine kinase ComD. However, since the comC
and comE mutants were just as sensitive for carolacton
as the wildtype, and since there was still considerable
activity of carolacton against the comD mutant, other
mechanisms must be more important.
Influence of carolacton on a pcomX luciferase reporter
strain
ComX, an alternative sigma-factor, plays a key role in
the quorum sensing system of S. mutans which controls
not only genetic competence, but also stress tolerance
and biofilm formation, leading to the suggestion to call
it the “X-state” rather than competence [39]. ComX is
positively induced by CSP through the response regula-
tor ComE, but also by another two component system,
CiaRH, and environmental stress [40]. ComX controls
the late competence genes, including the machinery for
DNA-uptake and processing, but also many other den-
sity dependent traits [36,40-42]. Altogether 240 genes
are directly or indirectly controlled by ComX [42]. To
investigate the effect of carolacton on the promoter
activity of comX a pcomX-luciferase reporter strain was
constructed. For the experiment a concentration of CSP
(200 nM) was chosen that induced competence without
causing substantial growth inhibition [42]. Figure 8A
shows that a severe reduction of CSP-induced comX
expression was caused by addition of carolacton to bio-
films grown anaerobically. Furthermore carolacton led
to a decrease of growth-dependent, basal comX-reporter
activity. Maximum inhibition was seen 60 min post
induction at the peak of comX expression. In planktonic
culture (Figure 8B) similar results were obtained, but
both the CSP induced expression of comX and its inhi-
bition through carolacton occurred over a longer time,
e.g. from 45 to 180 min post induction, possibly reflect-
ing the lower cell density in the planktonic culture.
Furthermore we found that carolacton reduced the
growth-dependent comX-promoter activity of this repor-
ter strain also in the absence of externally added CSP,
both in biofilms and in planktonic culture.
Discussion
Dental caries, gingivitis, and periodontal diseases, which
may develop as a consequence of dental plaque
Figure 7 Damage of biofilms of S. mutans wildtype and knock-
out mutants for comC, comD and comE by carolacton. Biofilms
were grown under anaerobic conditions for 24 h and stained with
the LIVE/DEAD BacLight Bacterial Viability staining kit. Green and red
fluorescence was determined in triplicate samples, and biofilm
damage was calculated as reduction of the fluorescence ratio
green/red compared to untreated controls. Standard deviations
were calculated from 3 - 5 independent experiments.
Kunze et al. BMC Microbiology 2010, 10:199
http://www.biomedcentral.com/1471-2180/10/199
Page 7 of 13formation, are among the most common bacterial infec-
tions in humans. Eradication of cariogenic bacteria
within dental plaque is notoriously difficult and there-
fore new drugs and drug applications are constantly
being tested. In this study we successfully explored the
possibility to use secondary metabolites from a group of
soil bacteria producing diverse novel structures with a
large spectrum of mechanisms of action, as inhibitors of
biofilms of S. mutans, a bacterium which plays a key
role in dental biofilm formation and dental caries. One
such compound, carolacton, proved to strongly disturb
biofilm formation of S. mutans.
Carolacton has been isolated from a myxobacterium of
the species S. cellulosum, and was among the substances
which were not developed further because it was “inac-
tive”, e.g. showed no significant antibiotic or antifungal
Figure 8 Effect of carolacton on the comX-promoter activity of S. mutans. The CSP-induced comX-luc gene expression in the reporter strain
construct was determined in the presence and absence of 2 μM carolacton. The luciferase activity was normalized against the optical density at
620 nm and measured for different time-points after induction of luciferase expression with 0.2 μM CSP. The expression of comX-luc in cultures
which were not induced by externally added CSP and its inhibition by carolacton is also shown. Cultures were grown under anaerobic
conditions as biofilms (A) or in suspension (B).
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described here resulted in the discovery of a promising
biological activity for carolacton. Our study clearly
demonstrates that carolacton showed high antimicrobial
activity against biofilms of S. mutans,w h i l ep l a n k t o n i c
growth of bacteria, including S. mutans,w a so n l y
slightly affected. Thus, carolacton appears to target a
mechanism specific for biofilm development of
S. mutans.
The data show that in biofilms carolacton causes
membrane damage and cell death as well as morpholo-
gical changes, e.g. elongated cells, increased chain length
and bulging. Total biofilm mass was only temporarily
reduced during the first 12 h of biofilm growth, but not
in the later stages under the conditions tested here. The
dose-response curve of the activity of carolacton showed
a very low threshold concentration of 10 nM and no
substantial increase of activity above this concentration,
suggesting that it acts as a trigger/inhibitor of a signal-
ling pathway. We hypothesized that carolacton might
induce cell death and possibly reduced acid tolerance
(resulting in elongated or bulged cells) by interfering
with the competence and stress related cell-cell signal-
ling network in S. mutans. This network is comprised in
part of pheromone CSP (the comCDE system)-depen-
dent and CSP independent components which respond
to environmental signals [40,42,43]. CSP can trigger cell
death at high concentrations by inducing an auto-active
intracellular bacteriocin, CipB, in a fraction of the bio-
film cells [42]. In some ways the activity of carolacton is
similar to that of CSP at concentrations above those
that induce competence. CSP and carolacton both
induce balloon like cell morphology, and cell death in
about 50% of the biofilm cells, an effect which was not
increased by increasing their concentration [33]. Unlike
carolacton (see below), CSP activity is exclusively
mediated through comDE,i . e .t h ecomC and comD null
mutants were insensitive to CSP [33]. We studied the
response of mutants lacking functional comC, comD or
comE to carolacton. Only the comD mutant showed
slightly less biofilm damage than the wildtype. The histi-
dine kinase ComD induces transcription of the “early”
competence genes, among them 5 mutacins and the
sigma factor ComX. ComX then triggers the expression
of the “late” competence genes. The lack of ComD
controlled synthesis of mutacins, among them an autoly-
sin, and their corresponding immunity proteins and
membrane transporters, and the reduced expression of
the late competence genes, including stress tolerance
genes, in the ΔcomD mutant strain, apparently makes
this mutant more resistant to carolacton, although only
to a small extent.
However, other mechanisms must be operating as
well, since this mutant was still damaged by about 40%.
Fourteen two-component systems consisting of a histi-
dine kinase (HK) and a response regulator (RR) have
been identified in S. mutans [44,45]. In addition to
ComDE, genetic competence is also mediated through
VicRK (HK/RR1) [46], the CiaHR (HK/RR2) [40], and
the HK/RR11 [36,47]. Moreover, immunity against auto-
lysis is controlled in a density dependent way by LiaSR
(formerly HK/RR11)[48]. Carolacton might therefore act
not only or not primarily on ComD, but also on some
of the other two component systems of S. mutans.
To obtain further insights into the possible mode of
action of carolacton, we then studied its effect on the
expression of ComX, the alternate sigma factor of
S. mutans which is induced by CSP and stress and con-
trols not only genetic competence [41], but also stress
related traits. Altogether 240 genes are directly or indir-
ectly controlled by comX [42]. The data show that
indeed the expression of pcomX after induction by CSP
is strongly inhibited by carolacton, suggesting that caro-
lacton interferes with the ComX related signalling net-
work in S. mutans. The alternate sigma factor ComX
controls the expression of the so-called “late” compe-
tence genes. They comprise the complete cellular
machinery for uptake and processing of DNA, repre-
senting the essential mechanism for genetic competence.
In addition, stress related phenotypes are also controlled
by comX [42]. Competence is not only induced by the
ComDE mediated signaling cascade, but several other
two-component systems and response regulators are
also involved, e.g. CiaH, HtrA [40], HK11/RR11 [47],
and the VicRK system [46]. Therefore, CSP related and
CSP independent signaling cascades exist for inducing
competence and stress tolerance, which however all rely
on the late competence genes and thus converge on
comX induction. A reduction in the expression of comX
by carolacton after CSP stimulation could therefore be
caused by a direct interaction of carolacton with ComD,
with CSP, or with the binding of CSP to ComD, result-
ing in an impaired signaling cascade and reduced comX
expression. Since a ΔcomD mutant, which cannot
respond to CSP through ComD, shows only slightly
reduced sensitivity to carolacton, this scenario is not
supported by the data. It appears more likely that one of
the other two-component systems involved in compe-
tence regulation or stress response is inhibited by caro-
lacton, and that this inhibition is relayed to comX via
the specific signaling cascade. The comD gene was
shown to be differentially expressed in a RR11 mutant
[47], and therefore an indirect effect of carolacton on
comD expression through one of the other two-compo-
nent systems is also possible.
Other mechanisms could also contribute to cell death
in a growth dependent way. For example, the gene atlA
was discovered to decrease autolysis and cause
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[49,50]. Interestingly, the ΔcomD mutant, which is
unable to induce comX expression after CSP stimulation,
was slightly less sensitive to carolacton, but carolacton
reduced the CSP induced comX expression, which
appears to be contradictory. However, the sigma factor
comX and the histidine kinase comD are connected
through a complex signaling network which receives
input from several histidine kinases as well as additional
regulators. The experimental conditions analysed here,
e.g. knock-out of comD, and determination of comX
expression after CSP stimulation, both are highly artifi-
cial. Thus, since the mechanism of carolacton is not
known, the causal relationship between them cannot be
inferred from the data presented here. ComD plays
apparently only a small role for the effect of carolacton.
If one or several of the other thirteen two-component
systems of S. mutans are affected by carolacton, this
could lead to the observed result with the highly sensi-
tive pcomX reporter strain. A transcriptome analysis
would be needed to determine the effect of carolacton
on comD and comX expression as well as on the other
two-component systems of S. mutans under “natural”
conditions, d.h. without additional stimulation by CSP.
CSP has been shown to inhibit biofilms and to cause
elongated cells at high concentrations [33]. Antibacterial
activity of other peptides has been tested against
S. mutans, but relatively high concentrations are
required [51]. Killing activity was therefore enhanced by
a combination of inhibitory peptides with desinfectants
[52]. Killing activity has also been enhanced by con-
structing synthetic peptides consisting of two inhibitory
domains [53]. In another approach, the cytotoxic effect
of inhibitory peptides was combined with the specificity
of the ComD receptor, resulting in so called STAMPs
(targeted antimicrobial peptides). Such STAMPs
were constructed by fusing an inhibitory peptide with a
targeting domain derived from CSP [54]. By contrast,
carolacton is structurally unrelated to peptide phero-
mones. Proof of principle for using chemically unrelated
compounds as inhibitors has been obtained for the acy-
lated homoserine lactone based quorum sensing system
of Gram negative bacteria [55].
Conclusions
Bacterial signalling systems have emerged in recent
years as attractive targets for antimicrobial therapy. The
discovery of a compound damaging S. mutans biofilms
which might be targeting one or several of its two-com-
ponent systems involved in regulating biofilm formation,
autolysis and stress tolerance could provide a novel
approach for future therapeutic strategies to prevent
dental plaque related diseases with only minimal impact
on the normal microbial flora.
Methods
Bacterial strains and culture conditions
S. mutans wild-type strain UA159 (ATCC 700610) and
its knockout mutants defective in the quorum sensing
genes comC, comD,o rcomE have been provided by
courtesy of Prof. Dr. D. G. Cvitkovitch from the Univer-
sity of Toronto, Canada. The mutants were constructed
by allelic replacement of the gene in question with an
erythromycin resistance cassette using the PCR ligation
mutagenesis strategy described in more detail in [56].
The wild-type strain was maintained routinely on Todd-
Hewitt (TH) agar plates (Difco) and liquid cultures were
grown in Todd-Hewitt broth Bacto™(THB). For cultiva-
tion of the mutants, erythromycin was added at 10 μg
per ml to the media. For biofilm growth, THB was sup-
plemented with 0.5% sucrose (THBS). Incubation was at
37°C without agitation under aerobic (with 10% CO2)o r
anaerobic (80% N2,1 0 %H 2,1 0 %C O 2) conditions. For
anaerobic growth, the medium was flushed with nitro-
gen before use. Escherichia coli DH5a was used as clon-
ing strain and routinely cultured in Luria Bertani (LB,
Carl-Roth, Karlsruhe, Germany) medium at 37°C. E. coli
strains carrying plasmids were selected with 50 μgm l
-1
spectinomycin.
Inhibition of planktonic growth and determination of
cytotoxicity
The minimal inhibitory concentration of carolacton on
planktonic growth of S. mutans UA159 was determined
with the conventional serial two-fold dilution method in
96-well microtiter plates (200 μl/well). As inoculum 1 ×
10
6 cells/ml were used, and carolacton was dissolved in
MeOH, producing concentrations in the cultures of not
more than 5%. Incubation was for 24 hours at 37°C
under both anaerobic and aerobic conditions. Optical
density (OD) measurements at 620 nm were performed
using a Wallac Victor3™1420 Multilabel Counter (Per-
kin-Elmer Life Sciences). Acute cytotoxicity against
L929 mouse cells (connective tissue, ATCC CCL 1) was
determined using an MTT assay as reported [57].
Cytoplasmic histone-associatd DNA fragments were
measured with the Cell Death Detection ELISA kit from
Roche Diagnostic to determine apoptosis induction in
L929 cells. Cells were inoculated at 10000 cells/well in a
96-well plate, grown to sub-confluence for 2 days and
then incubated with different concentrations of carolac-
ton for 18 hours.
Biofilm cultivation
Biofilm formation was induced in 96-well polystyrene
flat-bottom microtiter plates (Greiner bio-one, μClear-
Plate Black). Overnight cultures of S. mutans UA159
and its corresponding mutants grown anaerobically
in THB (if necessary in the presence of 10 μg/ml
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fresh THB with the addition of 0.5% (w/v) sucrose.
Aliquots thereof (95 μl) were distributed into microtiter
plate wells, which contained 5 μl of different concentra-
tions of a test compound or alternatively 5 μl of metha-
nol as control. All measurements were done in
triplicate. The microtiter plates were incubated at 37°C
without shaking under anaerobic conditions for 24 h
unless indicated otherwise.
Determination of cell viability by counting colony
forming units (CFU)
Samples were serially diluted in 0.85% NaCl, and two to
three appropriate dilutions were plated in triplicate onto
TH agar and incubated anaerobically at 37°C for 2 days
before counting. For enumerating biofilm CFUs, biofilms
were scraped off from the bottom of the wells using pip-
ette tips, resuspended in 0.85% NaCl, vortexed for 1 min
and treated as above.
LIVE/DEAD BacLight bacterial viability staining
Biofilms were analysed using the LIVE/DEAD BacLight
bacterial viability staining kit L13152 (Invitrogen, Mole-
cular Probes, Inc. Eugene, OR, USA) according to the
manufacturer’s instructions. The kit consists of two
stains, propidium iodide and SYTO9, which both stain
nucleic acids. When used alone, green fluorescing
SYTO9 generally labels all bacteria in a population,
whereas red fluorescing propidium iodide only pene-
trates bacteria with damaged membranes, causing a
reduction in the SYTO9 stain fluorescence. Thus with
an appropriate mixture of the SYTO9 and Ppropidium
iodide stains, bacteria with intact membranes stain
fluorescent green, and bacteria with damaged mem-
branes stain fluorescent red. Staining of biofilms was
usually carried out for 15 min in the dark at room tem-
perature with 100 μl of a 1:1 mixture of the two dye
components. In some experiments biofilms were also
stained exclusively with the green fluorescing compo-
nent SYTO9. To remove planktonic and loosely bound
bacteria the biofilms were carefully washed before stain-
ing with 100 μl of 0.85% NaCl. Fluorescence was mea-
sured in a microtiter plate reader (Wallac Victor3™1420
Multilabel Counter, Perkin-Elmer Life Sciences)
equipped with detectors and filter sets for monitoring
red (630 nm) and green (535 nm) fluorescence. Results
are expressed as reduction of the ratio of green/red
fluorescence compared to untreated controls.
Construction of a pcomX luciferase reporter strain and
luciferase assay
For the construction of the luciferase reporter strains,
the advanced firefly luciferase gene was amplified using
Pfu polymerase from plasmid pHL222 (Lößner et al.,
unpuplished) by utilisation of primers lucF (5’ATATAC-
CATGGAAGACGCCAAAAAC) and lucR (5’-AAAAAAA
CTAGTTTATGCTAGTTATTGCTCAGCGG-3’)b e a r i n g
restriction sites (bold) for NcoI and SpeI. The amplicon
was cloned into the suicide vector pFW5 [58] via the NcoI
and SpeI sites to generate plasmid pALEC15. A fragment
comprising approximately 1 kb of sequence upstream of
the comX start codon was PCR-amplified using genomic
DNA of S. mutans UA159 as template
(Primer pair P102_1997 For (5’-AAAAAAACCAT
GGTCCAAAAATAAGTGACTAAGG-3’) and P103_1997
Rev (5’-AAAAAAACCATGGCTATTACGATGACCTCC
TTT-3’)). Restriction sites for NcoI (bold) were introduced
via the 5’ termini of the PCR primers. The digested ampli-
con was ligated into the vector pALEC15 cut with the
same enzyme and containing the promoterless luciferase
gene and a spectinomycin resistance cassette. Constructs
confirmed by PCR and sequencing were transformed in
S. mutans UA159 according to the method of Li et al [34]
and chromosomally integrated via single crossover homo-
logous recombination. Transformed cells were plated on
selective THY agar with spectinomycin (600 μg/ml) and
single colonies were picked. For the confirmation of the
expected integration a PCR was performed and the iden-
tity of the integrated DNA was confirmed by sequencing
In addition the inductivity of clones with CSP was tested
as positive control [41]. The luciferase assay was per-
formed in optical 96 well polystyrene white microtiter
plates (Nunc) as described by Loimaranta et al. [59].
Briefly, overnight cultures of the pcomX-luciferase repor-
ter strain of S. mutans were diluted 1:10 in fresh THB-
media (pH 6.5) and grown for one hour at 37°C under
anaerobic conditions. Aliquots of 100 μl of cells were
taken as reference sample before CSP-induction. Subse-
quently 2 μM carolacton and/or 200 nM CSP were
added to the cells and samples were taken at different
timepoints post induction. The production of luciferase
was stopped by an immediate cold-shock and an incuba-
tion on ice. In addition the luminescence of untreated
cells was also determined. For the assay 100 μlo ft h e
samples were diluted with 100 μlo fg l u c o s e - c o n t a i n i n g
buffer (2% glucose, 0.9 mM ATP, 25 mM tricine, 5 mM
MgSO4, 0.5 mM EDTA, 0.5 mM DTT to ensure
sufficient levels of intracellular ATP. After incubation
for 10 minutes at room temperature 100 μl of 360 μM
D-luciferin in 20 mM tricine was added through a
dispenser and luminescence was measured in a Victor
X-Light™1420 Luminescence Plate Reader (Perkin Elmer
Life Sciences). For an appropriate comparison of the
different samples the luminescence was normalized
against the optical density at 620 nm wavelength. The
mean of at least three independent biological samples
was determined, and each experiment was repeated at
least twice.
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ase activity in biofilms, an overnight culture of the
S. mutans pcomX-luciferase reporter strain was diluted
in fresh THBS-medium to an OD600 =0 , 0 5 .T h e
biofilms were grown in an polystyrene 96 well micro-
titer-plate (Greiner BioOne, Frickenhausen, Germany)
containing 200 μlo fc e l lc u l t u r ep e rw e l l .A f t e r3 , 5h
of growth (37°C, anaerobic conditions) the superna-
tant was completely removed and replaced with fresh
THBS-medium containing 200 nM CSP and/or 2 μM
carolacton. Untreated cells were used as reference
samples. At least three wells were used as replicates
for each condition tested. Samples were harvested at
different time points following supplementation of
CSP and/or carolacton using a rubber scraper.
Scraped off cells were resuspended in 200 μlo fT H B S
and the luciferase assay was performed as described
above.
Confocal Laser Scanning Microscopy
Biofilms developed on half area 96-well polystyrene
flat-bottom microtiter plates for 12 or 23 h in triplicate
and stained with the LIVE/DEAD BacLight viability kit
(see above) were observed using an Olympus FlowView
1000 (Olympus, Tokyo, Japan) confocal laser scanning
microscope. To acquire green ("live”) and red ("dead”)
fluorescence, respectively, a laser excitation at 488 nm
(Ar laser) and 561 nm (He laser) and emission filters at
500 - 545 nm and 580 - 680 nm were used. Image data
were subsequently processed with the Imaris software
(Bitplane AG, Zürich, Switzerland).
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